LabMinds
About LabMinds
LabMinds is the leader in AI and robotics for solution preparation in pharmaceutical and life science labs. A cornerstone of R&D and QA/QC processes, solution preparation continues to be a highly manual process with many moving parts, exposing labs to considerable risk and inevitable waste. LabMinds’ platform addresses these challenges with powerful AI software combined with state-of-the-art robotics to safeguard against tainted inputs, enable near-perfect accuracy, and attain unmatched control. Further, labs in the LabMinds network contribute to, and benefit from, the collection of input and sensor data throughout the solution prep process; it’s never been easier to gain detailed insight into how chemicals interact with each other. By implementing more security and order, and leveraging the power of big data, LabMinds moves ever closer to achieving its mission to enable scientists and businesses to build and optimize labs, in order to bring meaningful therapies to market sooner.
Company Metrics
- Employees: 11-50
- Monthly Visits: 1864
- Tech Stack: 19 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 9400000 USD
- Last Funding: 6400000 USD (Undisclosed)
- Funding Status: M&A
Technology Stack
LabMinds actively uses 19 products in their tech stack.
Market Presence
Industries: 3D Printing, Artificial Intelligence, Biopharma, Biotechnology, Hardware, Life Science, Machine Learning, Robotics, Software
Headquarters: Boston, Massachusetts, United States
Leadership
- Jeff Caputo - President & CEO LinkedIn